Literature DB >> 27662646

Progesterone in normal and pathological pregnancy.

Gian Carlo Di Renzo, Irene Giardina, Graziano Clerici, Eleonora Brillo, Sandro Gerli.   

Abstract

Progesterone is an essential hormone in the process of reproduction. It is involved in the menstrual cycle, implantation and is essential for pregnancy maintenance. It has been proposed and extensively used in the treatment of different gynecological pathologies as well as in assisted reproductive technologies and in the maintenance of pregnancy. Called "the pregnancy hormone", natural progesterone is essential before pregnancy and has a crucial role in its maintenance based on different mechanisms such as: modulation of maternal immune response and suppression of inflammatory response (the presence of progesterone and its interaction with progesterone receptors at the decidua level appears to play a major role in the maternal defense strategy), reduction of uterine contractility (adequate progesterone concentrations in myometrium are able to counteract prostaglandin stimulatory activity as well as oxytocin), improvement of utero-placental circulation and luteal phase support (it has been demonstrated that progesterone may promote the invasion of extravillous trophoblasts to the decidua by inhibiting apoptosis of extravillous trophoblasts). Once the therapeutic need of progesterone is established, the key factor is the decision of the best route to administer the hormone and the optimal dosage determination. Progesterone can be administered by many different routes, but the most utilized are oral, the vaginal and intramuscular administration. The main uses of progesterone are represented by: threatened miscarriage, recurrent miscarriage and preterm birth (in the prevention strategy, as a tocolytic agent and also in the maintenance of uterine quiescence).

Mesh:

Substances:

Year:  2016        PMID: 27662646     DOI: 10.1515/hmbci-2016-0038

Source DB:  PubMed          Journal:  Horm Mol Biol Clin Investig        ISSN: 1868-1883


  31 in total

1.  Sex dimorphic regulation of osteoprogenitor progesterone in bone stromal cells.

Authors:  Alexander Kot; Zhendong A Zhong; Hongliang Zhang; Yu-An Evan Lay; Nancy E Lane; Wei Yao
Journal:  J Mol Endocrinol       Date:  2017-09-04       Impact factor: 5.098

2.  Th17/Treg-cell balance in the peripheral blood of pregnant females with a history of recurrent spontaneous abortion receiving progesterone or cyclosporine A.

Authors:  Songcun Wang; Mengdie Li; Fengrun Sun; Chunqin Chen; Jiangfeng Ye; Dajin Li; Jinfeng Qian; Meirong Du
Journal:  Exp Ther Med       Date:  2020-11-17       Impact factor: 2.447

3.  LNG-IUS combined with progesterone ameliorates endometrial thickness and pregnancy outcomes of patients with early-stage endometrial cancer or atypical hyperplasia.

Authors:  Fang Fang; Hao Xu; Ling Wu; Linyi Hu; Ying Liu; Yinnan Li; Chunhua Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth.

Authors:  Thuy Hoang; Hannah Zierden; Abhijit Date; Jairo Ortiz; Sanjeev Gumber; Nicole Anders; Ping He; James Segars; Justin Hanes; Mala Mahendroo; Laura M Ensign
Journal:  J Control Release       Date:  2018-12-28       Impact factor: 9.776

Review 5.  Endocrine disruptors of sex hormone activities.

Authors:  L Varticovski; D A Stavreva; A McGowan; R Raziuddin; G L Hager
Journal:  Mol Cell Endocrinol       Date:  2021-07-30       Impact factor: 4.102

6.  Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth.

Authors:  Hannah C Zierden; Jairo I Ortiz; Kevin DeLong; Jingqi Yu; Gaoshan Li; Peter Dimitrion; Sabrine Bensouda; Victoria Laney; Anna Bailey; Nicole M Anders; Morgan Scardina; Mala Mahendroo; Sam Mesiano; Irina Burd; Gunter Wagner; Justin Hanes; Laura M Ensign
Journal:  Sci Transl Med       Date:  2021-01-13       Impact factor: 17.956

7.  Oral versus Vaginal Micronized Progesterone for the Treatment of Threatened Miscarriage.

Authors:  Rashida Parveen; Mehnaz Khakwani; Sobia Tabassum; Sajjad Masood
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

8.  Mifepristone (RU486) inhibits dietary lipid digestion by antagonizing the role of glucocorticoid receptor on lipase transcription.

Authors:  Peng Ma; Yao Zhang; Qiying Liang; Youjie Yin; Saifei Wang; Ruolei Han; Chunyu Huo; Hansong Deng
Journal:  iScience       Date:  2021-05-12

9.  Polymorphism, expression and structure analysis of key genes in the ovarian steroidogenesis pathway in sheep (Ovis aries).

Authors:  Wen-Ping Hu; Ming-Qiu Liu; Zhi-Long Tian; Qiu-Yue Liu; Zhuang-Biao Zhang; Ji-Shun Tang; Xiao-Yun He; Yan-Yan Zhu; Yuan-Yuan Wang; Ming-Xing Chu
Journal:  Vet Med Sci       Date:  2021-03-29

Review 10.  The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis.

Authors:  Hee Joong Lee; Tae Chul Park; Jae Hoon Kim; Errol Norwitz; Banghyun Lee
Journal:  Biomed Res Int       Date:  2017-12-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.